BMS Buys Into BioNTech Bispecific Antibody, Putting Up $1.5B to Collaborate in Multiple Cancers
BioNTech’s oncology technique facilities on a bispecific antibody that the corporate envisions because the spine of many potential drug combos ...
Tag: 1.5B
RECOMMENDED
Key Medicare Advantage player pivots from artery testing to bitcoin
For many of its 18-year historical past, Semler Scientific marketed a single medical product that grew to become a well-liked...
Stay informed with the latest news, articles, and insights on agarwood cultivation, history, sustainability, and more. Explore the timeless allure of agarwood and deepen your understanding of this extraordinary natural resource.